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concentration when nephrologists face uremic depres-Depression in dialysis
sion? If rubidium deficiency is confirmed, it might allow
supplementation, which could add to the tools for thepatients: Rubidium
war against uremic depression.
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many data prove that a true rubidium deficiency occurs
in dialysis patients [3, 4]: (1) reduced tissue, including
Reply from the authorCNS (2250 1520 ng/g vs. 5490 1250 ng/g, P 0.0002)
Canavese et al raise the interesting notion that abnor-rubidium concentrations (Fig. 1); (2) lower serum rubid-
malities in trace elemental metabolism may be linkedium concentrations compared with normal people (304
with depression in patients treated for end-stage renal81 g/L vs. 350  74 g/L, P  0.001) with odd ratios
disease (ESRD) with hemodialysis (HD). This raisesfor rubidum 250 g/L  12.6, 95% CI 2.77 to 57.04;
points regarding the pluralistic aspects of assessing de-(3) low rubidium content (2 g/L) in solutions em-
pressive effect in patients with chronic medical illnessesployed for hemodialysis and intraperitoneal dialysis; and
[1, 2]. Rubidium plays a role in neurotransmission and(4) negative intradialytic rubidium balance (4.0  1.1
transport processes [3], as does zinc in mediating enzymemg/session).
activity and gene expression [3, 4]. Indeed, abnormalObviously, rubidium supplementation cannot modify
zinc metabolism has been linked to both inflammationthe burden of the illness, just as all the other therapeutic
options did not [1]. However, why not look for rubidium and depression in patients in both the absence of renal
Fig. 1. Rubidium concentrations in tissues of
dialysis patients () compared with normal
people ( ).
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